2b15 Citations

The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.

Acta Crystallogr D Biol Crystallogr 62 512-9 (2006)
Related entries: 2b14, 2b16

Cited: 21 times
EuropePMC logo PMID: 16627944

Abstract

Systemic deposition of transthyretin (TTR) amyloid fibrils is always observed in familial amyloidotic polyneuropathy, senile systemic amyloidosis and familial amyloidotic cardiomyopathy patients. Destabilization of the molecule leads to a cascade of events which result in fibril formation. The destabilization of a native protein with consequent conformational changes appears to be a common link in several human amyloid diseases. Intensive research has been directed towards finding small molecules that could work as therapeutic agents for the prevention/inhibition of amyloid diseases through stabilization of the native fold of the potentially amyloidogenic protein. This work provides insight into the structural determinants of the highly stabilizing effects of 2,4-dinitrophenol on wild-type TTR. It is also shown that similar interactions are established between this molecule and two highly amyloidogenic TTR variants: TTR L55P and TTR Y78F. In the three crystal complexes, 2,4-dinitrophenol occupies the two hormone-binding sites of the TTR tetramer. As a result of 2,4-dinitrophenol binding, the two dimers in the TTR tetramer become closer, increasing the stability of the protein. The three-dimensional structures now determined allow a comprehensive description of key interactions between transthyretin and 2,4-dinitrophenol, a small compound that holds promise as a template for the design of a therapeutical drug for amyloid diseases.

Reviews - 2b15 mentioned but not cited (1)

  1. Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen. Lazarus P, Blevins-Primeau AS, Zheng Y, Sun D. Ann N Y Acad Sci 1155 99-111 (2009)

Articles - 2b15 mentioned but not cited (14)

  1. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation. Lewis BC, Mackenzie PI, Elliot DJ, Burchell B, Bhasker CR, Miners JO. Biochem Pharmacol 73 1463-1473 (2007)
  2. Mapping the Cell-Surface N-Glycoproteome of Human Hepatocytes Reveals Markers for Selecting a Homogeneous Population of iPSC-Derived Hepatocytes. Mallanna SK, Cayo MA, Twaroski K, Gundry RL, Duncan SA. Stem Cell Reports 7 543-556 (2016)
  3. Response of the mitochondrial proteome of rat renal proximal convoluted tubules to chronic metabolic acidosis. Freund DM, Prenni JE, Curthoys NP. Am J Physiol Renal Physiol 304 F145-55 (2013)
  4. Improved detection of quantitative differences using a combination of spectral counting and MS/MS total ion current. Freund DM, Prenni JE. J Proteome Res 12 1996-2004 (2013)
  5. RNA sequence analysis of rat acute experimental pancreatitis with and without fatty liver: a gene expression profiling comparative study. Wang Q, Yan H, Wang G, Qiu Z, Bai B, Wang S, Yu P, Feng Q, Zhao Q, He X, Liu C. Sci Rep 7 734 (2017)
  6. The Phylogeny of Osteopontin-Analysis of the Protein Sequence. Weber GF. Int J Mol Sci 19 E2557 (2018)
  7. Interpreting the Molecular Mechanisms of Yinchenhao Decoction on Hepatocellular Carcinoma through Absorbed Components Based on Network Pharmacology. Sun J, Han T, Yang T, Chen Y, Huang J. Biomed Res Int 2021 6616908 (2021)
  8. Proteomic Analysis of Liver Proteins in a Rat Model of Chronic Restraint Stress-Induced Depression. Li C, Guo Z, Zhao R, Sun W, Xie M. Biomed Res Int 2017 7508316 (2017)
  9. Identification of regulatory motifs in the CHO genome for stable monoclonal antibody production. Takagi Y, Yamazaki T, Masuda K, Nishii S, Kawakami B, Omasa T. Cytotechnology 69 451-460 (2017)
  10. Insight into tartrate inhibition patterns in vitro and in vivo based on cocrystal structure with UDP-glucuronosyltransferase 2B15. Zhang L, Zhu L, Qu W, Wu F, Hu M, Xie W, Liu Z, Wang C. Biochem Pharmacol 172 113753 (2020)
  11. Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer. Wei Z, Han D, Zhang C, Wang S, Liu J, Chao F, Song Z, Chen G. Front Oncol 12 893424 (2022)
  12. Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19. Aminpour M, Delgado WEM, Wacker S, Noskov S, Houghton M, Tyrrell DLJ, Tuszynski JA. BMC Pharmacol Toxicol 22 61 (2021)
  13. Endophytic Fungi Associated with Aquilaria sinensis (Agarwood) from China Show Antagonism against Bacterial and Fungal Pathogens. Du TY, Karunarathna SC, Zhang X, Dai DQ, Mapook A, Suwannarach N, Xu JC, Stephenson SL, Elgorban AM, Al-Rejaie S, Tibpromma S. J Fungi (Basel) 8 1197 (2022)
  14. Label-free drug interaction screening via Raman microscopy. Altangerel N, Neuman BW, Hemmer PR, Yakovlev VV, Rajil N, Yi Z, Sokolov AV, Scully MO. Proc Natl Acad Sci U S A 120 e2218826120 (2023)


Reviews citing this publication (2)

  1. Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Connelly S, Choi S, Johnson SM, Kelly JW, Wilson IA. Curr Opin Struct Biol 20 54-62 (2010)
  2. Molecular and cellular aspects of protein misfolding and disease. Herczenik E, Gebbink MF. FASEB J 22 2115-2133 (2008)

Articles citing this publication (4)

  1. Gas-phase unfolding and disassembly reveals stability differences in ligand-bound multiprotein complexes. Hyung SJ, Robinson CV, Ruotolo BT. Chem Biol 16 382-390 (2009)
  2. Binding and stabilization of transthyretin by curcumin. Pullakhandam R, Srinivas PN, Nair MK, Reddy GB. Arch Biochem Biophys 485 115-119 (2009)
  3. The putative role of some conserved water molecules in the structure and function of human transthyretin. Banerjee A, Dasgupta S, Mukhopadhyay BP, Sekar K. Acta Crystallogr D Biol Crystallogr 71 2248-2266 (2015)
  4. The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis. Bemporad F, Leri M, Ramazzotti M, Stefani M, Bucciantini M. Pharmaceuticals (Basel) 15 277 (2022)